Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Clover Health Is Down Big. Is It a Buy?

TheMotleyFool

0 0

Chamath Palihapitiya has taken three companies public through his special-purpose acquisition companies (SPACs) and has announced a fourth in recent months. Since their merger announcements, all are handily outperforming the market but one -- Clover Health (NASDAQ: CLOV). In this Fool Live video clip, recorded on March 15, Fool.com contributors Matt Frankel, CFP, Brian Withers, and Dan Caplinger discuss why Clover Health has performed so poorly and whether the stock is worth a look for long-term investors now.

Source Fool.com

Like: 0

CLOV

Share